Proteomic Profiling Identifies Distinct Regulation of Proteins in Obese Diabetic Patients Treated with Metformin

<b>Background</b>: Obesity and type 2 diabetes mellitus (T2DM) are characterized by underlying low-grade chronic inflammation. Metformin has been used as the first line of therapy in T2DM as it decreases hepatic glucose production and glucose intestinal absorption, enhances insulin sensi...

Full description

Bibliographic Details

Published in:	Pharmaceuticals
Main Authors:	Awad Alshahrani, Ahmad Aljada, Afshan Masood, Muhammad Mujammami, Assim A. Alfadda, Mohthash Musambil, Ibrahim O. Alanazi, Mohammed Al Dubayee, Anas M. Abdel Rahman, Hicham Benabdelkamel
Format:	Article
Language:	English
Published:	MDPI AG 2023-09-01
Subjects:	metformin proteomics obesity type 2 diabetes mellitus mass spectrometry
Online Access:	https://www.mdpi.com/1424-8247/16/10/1345